Effect of cardiac resynchronisation therapy on occurrence of ventricular arrhythmia in patients with implantable cardioverter defibrillators undergoing upgrade to cardiac resynchronisation therapy devices

Heart

Volumn 94, Issue 2, 2008, Pages 186-190

  Lin, G ^a   Rea, R F ^a   Hammill, S C ^a   Hayes, D L ^a   Brady, Peter A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; MEXILETINE; NITRIC ACID DERIVATIVE; SOTALOL;

AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DEFIBRILLATOR; DEVICE; FEMALE; FREQUENCY ANALYSIS; HEALTH CARE FACILITY; HEART EJECTION FRACTION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TERTIARY HEALTH CARE; ARTIFICIAL HEART PACEMAKER; HEART ARRHYTHMIA; HEART ASSIST DEVICE; HEART FAILURE; HEART VENTRICLE REMODELING; IMPLANTATION; METHODOLOGY; PHYSIOLOGY; STROKE; SUDDEN DEATH; TREATMENT OUTCOME;

AGED; ARRHYTHMIAS, CARDIAC; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; MALE; PACEMAKER, ARTIFICIAL; PROSTHESIS IMPLANTATION; RETROSPECTIVE STUDIES; STROKE; TREATMENT OUTCOME; VENTRICULAR REMODELING;

EID: 38749134157     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2007.118372     Document Type: Article

References (16)

1. Young J, Abraham W, Smith A, et al, for Multisite InSync Randomization Clinical Evaluation (MIRACLE-ICD) investigators. Combined cardiac resynchronization and implantable cardioverter defibrillation in advanced chronic heart failure: the MIRACLE ICD trial. JAMA 2003;289:2685- 94.
2. Bristow M, Saxon L, Boehmer J, et al, for the Comparison of Medical Therapy Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable cardioverter defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-50.
3. Cleland J, Daubert J, Erdmann E, et al, for the Cardiac Resynchronization-Heart Failure (CARE-HF) study investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-49.
4. Ermis C, Seutter R, Zhu A, et al. Impact of upgrade to cardiac resynchronization therapy on ventricular arrhythmia frequency in patients with implantable cardioverter-defibrillators. J Am Coll Cardiol 2005;46:2258-63.
5. McSwain R, Schwartz R, DeLurgio D, et al. The impact of cardiac resynchronization therapy on ventricular tachycardia/fibrillation: an analysis from the combined Contak-CD and InSync-ICD studies. J Cardiovasc Electrophysiol 2005;16:1168-71.
6. Higgins S, Yong P, Scheck D, et al. Biventricular pacing diminishes the need for implantable cardioverter defibrillator therapy. J Am Coll Cardiol 2000;36:824-7.
7. Higgins S, Hummell J, Niazi I, et al. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol 2003;42:1454-9.
8. Kies P, Bax J, Molhoek S, et al. Effect of left ventricular remodeling after cardiac resynchronization therapy on frequency of ventricular arrhythmias. Am J Cardiol 2004;94:130-2.
9. Singh JP, Hall WJ, McNitt S, et al. Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II). J Am Coll Cardiol 2005;46:1712- 20.
10. Hunt S. ACC/AHA 2005 Guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2005;46:e1-82.
11. Guerra J, Wu J, Meller J, et al. Increase in ventricular tachycardia frequency after biventricular implantable cardioverter defibrillator upgrade. J Cardiovasc Electrophysiol 2003;14:1245-7.
12. Fish J, Di Diego J, Nesterenko V, et al. Epicardial activation of left ventricular wall prolongs QT interval and transmural dispersion of repolarization: implications for biventricular pacing. Circulation 2004;109:2136-42.
13. DiCori A, Bongiorni M, Arena G, et al. New-onset ventricular tachycardia after cardiac resynchronization therapy. J Interv Card Electrophysiol 2005;12:231-5.
14. Medina-Ravell V, Lankipalli R, Yan G, et al. Effect of epicardial or biventricular pacing to prolong QT interval and increase transmural dispersion of repolarization: does resynchronization therapy pose a risk for patients predisposed to long OT or torsade de pointes? Circulation 2003;107:740-6.
15. Cleland JGF, Daubert J-C, Erdmann E, et al. Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]. Eur Heart J 2006;27:1928-32.
16. Rivero-Ayerza M, Theuns DAMJ, Garcia-Garcia HM, et al. Effects of cardiac resynchronization therapy on overall mortality and mode of death: a meta-analysis of randomized controlled trials. Eur Heart J 2006;27:2682-8.